Brief: Edwards Lifesciences Q1 Adjusted EPS USD 0.78 Vs. IBES Estimate USD 0.73
23/04/2026 21:15
Apr 23 (Reuters) - Edwards Lifesciences Q1 sales USD 1,648.6 million vs. IBES estimate USD 1,596 million. Q1 EPS USD 0.66 outlook Q2 sales USD 1,660-1,740 million vs. IBES estimate USD 1,684 million outlook Q2 adjusted EPS USD 0.7-0.76 vs. IBES estimate USD 0.75
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals